First Time Loading...

Raia Drogasil SA
BOVESPA:RADL3

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
BOVESPA:RADL3
Watchlist
Price: 25.58 BRL -0.58% Market Closed
Updated: May 2, 2024

Intrinsic Value

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. [ Read More ]

The intrinsic value of one RADL3 stock under the Base Case scenario is 22.52 BRL. Compared to the current market price of 25.58 BRL, Raia Drogasil SA is Overvalued by 12%.

Key Points:
RADL3 Intrinsic Value
Base Case
22.52 BRL
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Raia Drogasil SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RADL3 stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Raia Drogasil SA

Provide an overview of the primary business activities
of Raia Drogasil SA.

What unique competitive advantages
does Raia Drogasil SA hold over its rivals?

What risks and challenges
does Raia Drogasil SA face in the near future?

Summarize the latest earnings call
of Raia Drogasil SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Raia Drogasil SA.

Provide P/S
for Raia Drogasil SA.

Provide P/E
for Raia Drogasil SA.

Provide P/OCF
for Raia Drogasil SA.

Provide P/FCFE
for Raia Drogasil SA.

Provide P/B
for Raia Drogasil SA.

Provide EV/S
for Raia Drogasil SA.

Provide EV/GP
for Raia Drogasil SA.

Provide EV/EBITDA
for Raia Drogasil SA.

Provide EV/EBIT
for Raia Drogasil SA.

Provide EV/OCF
for Raia Drogasil SA.

Provide EV/FCFF
for Raia Drogasil SA.

Provide EV/IC
for Raia Drogasil SA.

Show me price targets
for Raia Drogasil SA made by professional analysts.

What are the Revenue projections
for Raia Drogasil SA?

How accurate were the past Revenue estimates
for Raia Drogasil SA?

What are the Net Income projections
for Raia Drogasil SA?

How accurate were the past Net Income estimates
for Raia Drogasil SA?

What are the EPS projections
for Raia Drogasil SA?

How accurate were the past EPS estimates
for Raia Drogasil SA?

What are the EBIT projections
for Raia Drogasil SA?

How accurate were the past EBIT estimates
for Raia Drogasil SA?

Compare the revenue forecasts
for Raia Drogasil SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Raia Drogasil SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Raia Drogasil SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Raia Drogasil SA compared to its peers.

Compare the P/E ratios
of Raia Drogasil SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Raia Drogasil SA with its peers.

Analyze the financial leverage
of Raia Drogasil SA compared to its main competitors.

Show all profitability ratios
for Raia Drogasil SA.

Provide ROE
for Raia Drogasil SA.

Provide ROA
for Raia Drogasil SA.

Provide ROIC
for Raia Drogasil SA.

Provide ROCE
for Raia Drogasil SA.

Provide Gross Margin
for Raia Drogasil SA.

Provide Operating Margin
for Raia Drogasil SA.

Provide Net Margin
for Raia Drogasil SA.

Provide FCF Margin
for Raia Drogasil SA.

Show all solvency ratios
for Raia Drogasil SA.

Provide D/E Ratio
for Raia Drogasil SA.

Provide D/A Ratio
for Raia Drogasil SA.

Provide Interest Coverage Ratio
for Raia Drogasil SA.

Provide Altman Z-Score Ratio
for Raia Drogasil SA.

Provide Quick Ratio
for Raia Drogasil SA.

Provide Current Ratio
for Raia Drogasil SA.

Provide Cash Ratio
for Raia Drogasil SA.

What is the historical Revenue growth
over the last 5 years for Raia Drogasil SA?

What is the historical Net Income growth
over the last 5 years for Raia Drogasil SA?

What is the current Free Cash Flow
of Raia Drogasil SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Raia Drogasil SA.

Financials

Balance Sheet Decomposition
Raia Drogasil SA

Current Assets 11.6B
Cash & Short-Term Investments 412.3m
Receivables 3.8B
Other Current Assets 7.3B
Non-Current Assets 8.5B
Long-Term Investments 15m
PP&E 5.9B
Intangibles 1.9B
Other Non-Current Assets 662.8m
Current Liabilities 8.1B
Accounts Payable 5.1B
Accrued Liabilities 877.2m
Other Current Liabilities 2.1B
Non-Current Liabilities 6.1B
Long-Term Debt 5.6B
Other Non-Current Liabilities 454.5m
Efficiency

Earnings Waterfall
Raia Drogasil SA

Revenue
34B BRL
Cost of Revenue
-23.8B BRL
Gross Profit
10.2B BRL
Operating Expenses
-8B BRL
Operating Income
2.2B BRL
Other Expenses
-1.1B BRL
Net Income
1.1B BRL

Free Cash Flow Analysis
Raia Drogasil SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

RADL3 Profitability Score
Profitability Due Diligence

Raia Drogasil SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
57/100
Profitability
Score

Raia Drogasil SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

RADL3 Solvency Score
Solvency Due Diligence

Raia Drogasil SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
50/100
Solvency
Score

Raia Drogasil SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RADL3 Price Targets Summary
Raia Drogasil SA

Wall Street analysts forecast RADL3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RADL3 is 31.49 BRL with a low forecast of 24.24 BRL and a high forecast of 36.75 BRL.

Lowest
Price Target
24.24 BRL
5% Downside
Average
Price Target
31.49 BRL
23% Upside
Highest
Price Target
36.75 BRL
44% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

RADL3 Price
Raia Drogasil SA

1M 1M
-4%
6M 6M
+1%
1Y 1Y
+0%
3Y 3Y
+2%
5Y 5Y
+100%
10Y 10Y
+677%
Annual Price Range
25.58
52w Low
24.46
52w High
29.57
Price Metrics
Average Annual Return 17.46%
Standard Deviation of Annual Returns 33.74%
Max Drawdown -17%
Shares Statistics
Market Capitalization 43.9B BRL
Shares Outstanding 1 714 382 358
Percentage of Shares Shorted
N/A

RADL3 Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Raia Drogasil SA Logo
Raia Drogasil SA

Country

Brazil

Industry

Retail

Market Cap

43.9B BRL

Dividend Yield

0.77%

Description

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 50,573 full-time employees. The company went IPO on 2010-10-20. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The firm operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.

Contact

SAO PAULO
Sao Paulo
Av. Corifeu de Azevedo Marques, 3.097, Butanta
+551137695678.0
https://www.rd.com.br

IPO

2010-10-20

Employees

50 573

Officers

CEO & Member of Executive Board
Mr. Marcílio D'Amigo Pousada
VP of Finance & Administrative and Member of Executive Board
Mr. Antonio Carlos Coelho
VP of Corporate Planning, IR, M&A and Member of Executive Board
Mr. Eugênio De Zagottis
VP of Commercial & Marketing and Member of Executive Board
Mr. Marcello De Zagottis
VP of Digital Transformation & Member of Executive Board
Mr. Fernando Kozel Varela
VP of Store, Multichannel & Expansion Operations and Member of Executive Board
Mr. Renato Cepollina Raduan
Show More
VP of People, Culture & Sustainability and Member of Executive Board
Ms. Maria Susana De Souza
VP of Health Business & Member of Executive Board
Mr. Bruno Wright Pipponzi
Accountant & Technical Manager
Celso Pissi Filho
Director of IR, Corporate Affairs & Strategy
Flavio Fogaca
Show Less

See Also

Discover More
What is the Intrinsic Value of one RADL3 stock?

The intrinsic value of one RADL3 stock under the Base Case scenario is 22.52 BRL.

Is RADL3 stock undervalued or overvalued?

Compared to the current market price of 25.58 BRL, Raia Drogasil SA is Overvalued by 12%.